Table I. Characteristics of study cohort
CodeGenderAIM Viral LoadaCONV Viral LoadaAIM CD8+ T CellbCONV CD8+ T CellbAIM Severityc
E1339Male3,9684,3061,416,800441,0004
E1354Male7,846NA881,280975,2401
E1369Male98,26332,5011,154,400693,0005
E1376Female658,3781,4044,384,3801,060,80010
E1382Female79,859NA4,895,100852,6009
E1405Female62,1718,6012,692,250NA6
E1420Male151,34820,4361,986,600739,8607
E1427Female34,001107,3443,590,400862,4008
E1435Female54,29410,8633,703,880970,9003
E1438Male3,06312,8054,268,800960,9602
  • a DNA copies per million peripheral B cells.

  • b Absolute number per milliliter.

  • c Rank 1–10 (mild to severe). Based on calculated value from the following formula: atypical lymphocyte percentage + 10 × lymphadenopathy score (1–10) + CD8 percentage.

  • NA, not available.